Granpool Innovative Investments

Granpool Innovative Investments is a venture capital firm that focuses on seed to early-stage investments in software, biotechnology, and genetics industries, with a geographical focus on the UK and the US. The firm seeks to acquire significant minority stakes in innovative companies without any industrial or geographical focus, aiming to create a global network of ventures since its inception in 2015. Granpool is interested in fintech, finance, mobility, healthcare, robotics, IT, and VR-related developing companies with a presence in Asia, Europe, North and South America.

The firm's investment strategy involves backing early-stage startups in cutting-edge technologies and disruptive models globally, providing capital, strategic support, and active collaboration to scale businesses. Granpool's portfolio includes companies in sectors such as augmented reality, cyber security, fintech, healthcare, life sciences, quantum computing, and robotics. The firm has made 16 investments to date, with its most recent investment being in Eagle Genomics. Notable exits include OptoForce.

Granpool Innovative Investments operates with a global perspective, leveraging its international network to identify and support high-potential startups across various innovative sectors. The firm's approach emphasizes active collaboration with portfolio companies to drive growth and innovation, aiming to create value through strategic partnerships and investments in emerging technologies and markets.